List of corporate sponsors

We thank our corporate sponsors for making the work of fighting kidney disease on all fronts possible. These organizations help ensure that every kidney patient has access to health care and every person at risk for this chronic health condition is empowered to prevent it.

Meeting in an office conference room

Thank you to our major corporate sponsors

The following sponsors supported the programs and services of the American Kidney Fund with generous contributions of $5,000 or more in 2020. You can also view our Corporate Members here.

($500,000+)

AstraZeneca Pharmaceuticals LP

GlaxoSmithKline

($100,000–$499,999)

Akebia Therapeutics, Inc.

Alnylam Pharmaceuticals, Inc.

Amgen USA

Cara Therapeutics

DaVita Healthcare Partners, Inc 

FMC Renal Pharmaceuticals

Horizon Therapeutics

Otsuka America Pharmaceutical Inc.

Tricida Inc

Vertex, Inc.

($50,000–$99,999)

Abbott Nutrition

Alexion Pharmaceuticals, Inc.

Ardelyx, Inc.

Rockpointe Corporation

Satellite Healthcare Inc

Truist Foundation - formerly Suntrust

($25,000–$49,999)

Gentian

Quest Diagnostics

Relypsa, Inc.

Right Advisory LLC

Travere

($5,000–$24,999)

American Society of Nephrology

Apellis Pharmaceuticals, Inc.

Aurinia Biotechnology Innovation Organization (BIO)

ColorNet Printing & Graphics

Dime Community Bank

EventEQ

Federal Street Strategies LLC

Flushing Bank

Fresenius Medical Care Institute for Advanced Clinical Trials for Children

Interactive Strategies

Jaspan Schlesinger LLP

JPA Health Communications

King & Spalding LLP

Latham & Watkins

Mallinckrodt Inc.

Mercury Public Affairs

Natera

National Renal Administrators Association

Northleaf Capital Partners

Omeros Corporation

OPKO Health - Renal Division

Orases PhRMA

PROTEK Consulting

RKD Group

Rockwell Medical Technologies Inc

Satter Investment Management

SPG Fiduciary Partners of Raymond James

Spherix Global Insights

SplitOak Strategies LLC

The Cooking Doc, LLC 

The Meltzer Group NFP

Vendorin York Studios  

Pharmaceutical Funding

  • The total pharmaceutical revenue including donated product is $5,361,700
  • The percentage of revenue from pharmaceutical companies is 1.59%

Note: Compliance with the U.S. Department of Health and Human Services Office of the Inspector General Opinion 97-1, under which the HIPP program operates, prohibits HIPP (Health Insurance Premium Program) donors to be included in this list.

Con el AKF, su ayuda llega más lejos

Esto fue lo que lograron en 2021 sus donaciones al AKF.

134 transplants monthly

134 transplants monthly

134 kidney transplants per month made possible with AKF's support, more than any other organization.

66,000 patients

66,000 patients

More than 66,000 dialysis and recent transplant patients were able to afford health care coverage and other treatment-related expenses.

More than $70,000 in disaster grants

More than $70,000 in disaster grants

More than $70,000 provided to nearly 300 kidney patients affected by natural disasters.

51 scientists

51 scientists

51 alumni and current AKF scientists advanced nephrology research.

6,000 kidney health coaches

6,000 kidney health coaches

completed our training course to educate others about the importance of living a healthy lifestyle

More than 200 kids and teens

More than 200 kids and teens

connected with their peers in our National Virtual Camp Program for pediatric kidney patients.